PT-141, also known as Bremelanotide, is a synthetic peptide primarily prescribed to premenopausal women with hypoactive sexual desire disorder (HSDD). It boosts sexual desire by activating melanocortin receptors in the brain.
This article focuses on the potential side effects of PT-141. Although it can be an effective treatment for low sexual desire, it’s important to be aware of potential adverse reactions.
Before starting PT-141, and throughout your treatment, talk with your doctor about any concerns you have. They can help you weigh the benefits and risks and monitor you for any concerning symptoms. Understanding the benefits and risks of treatments like HCG and Enclomiphene, and being informed about PT-141 side effects is key to making the right decision for your health.